These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10532366)

  • 1. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma.
    Portellos M; Buckley EG; Freedman SF
    J AAPOS; 1998 Feb; 2(1):43-7. PubMed ID: 10532366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
    Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group.
    Hutzelmann JE; Polis AB; Michael AJ; Adamsons IA
    Acta Ophthalmol Scand; 1998 Dec; 76(6):717-22. PubMed ID: 9881560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of glaucoma with carbonic anhydrase inhibitors in eyewash: medium term retrospective experience with dorzolamide].
    Detry-Morel M; De Hoste F
    Bull Soc Belge Ophtalmol; 1997; 267():157-66. PubMed ID: 9745826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Fiscella RG; Adelman AE
    Retina; 1997; 17(3):222-31. PubMed ID: 9196934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of dorzolamide-timolol combination versus the concomitant drugs.
    Choudhri S; Wand M; Shields MB
    Am J Ophthalmol; 2000 Dec; 130(6):832-3. PubMed ID: 11124307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A topical or oral carbonic anhydrase inhibitor to control ocular hypertension after cataract surgery.
    Abbasoğlu E; Tekeli O; Celikdoğan A; Gürsel E
    Eur J Ophthalmol; 2000; 10(1):27-31. PubMed ID: 10744202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.
    Simmons ST;
    Clin Ther; 2001 Apr; 23(4):604-19. PubMed ID: 11354394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of dorzolamide for glaucoma.
    Gillies WE; Brooks AM
    Ophthalmic Surg Lasers; 1998 Sep; 29(9):728-32. PubMed ID: 9760608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.
    Francis BA; Du LT; Berke S; Ehrenhaus M; Minckler DS;
    J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of intraocular pressure between systemic and topical carbonic anhydrase inhibitors: a clinical masked, cross-over study.
    Centofanti M; Manni GL; Napoli D; Bucci MG
    Pharmacol Res; 1997 May; 35(5):481-5. PubMed ID: 9299215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification. 1999; 43 (5): 344-6.
    Chakraborty P; Villada JR; Tinu AT
    J R Coll Surg Edinb; 1999 Dec; 44(6):411-2. PubMed ID: 10612969
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypotensive effects of dorzolamide eyewash in maximal therapy glaucoma patients: a comparative study with oral acetazolamide.
    Manni GL; Centofanti M; Napoli D; Parisi V; Bucci MG
    Acta Ophthalmol Scand Suppl; 1997; (224):22-3. PubMed ID: 9589714
    [No Abstract]   [Full Text] [Related]  

  • 18. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K; Shirato S
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.
    Sugrue MF
    Prog Retin Eye Res; 2000 Jan; 19(1):87-112. PubMed ID: 10614682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans.
    Maus TL; Larsson LI; McLaren JW; Brubaker RF
    Arch Ophthalmol; 1997 Jan; 115(1):45-9. PubMed ID: 9006424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.